Target intelligence / Profile preview

DNA polymerase lambda (Pol λ) (Pol λ)

Target
Pol λ
Molecular classification
Enzyme, DNA polymerase, Lyase
01

Overview

DNA polymerase lambda (Pol λ), encoded by the POLL gene, is a member of the X family of DNA polymerases primarily involved in DNA repair [3, 5]. It plays a crucial role in non-homologous end joining (NHEJ) by filling gaps in double-strand breaks and serves as a key enzyme in base excision repair (BER) and translesion synthesis (TLS), particularly for bypassing oxidative lesions like 8-oxoguanine [1, 6, 15]. Pol λ also contributes to the diversification of the immune repertoire through its involvement in V(D)J recombination [3, 8]. In oncology, Pol λ is frequently overexpressed in tumors, which can lead to increased resistance to DNA-damaging chemotherapies [6, 9]. As a result, it is considered a promising therapeutic target; small-molecule inhibitors, such as rhodanine-based compounds, are being explored to enhance the efficacy of treatments like temozolomide by preventing the repair of drug-induced DNA lesions [4, 11].

Other names
POLLDNA polymerase beta-2DNA polymerase beta-NDNA polymerase kappaPolymerase (DNA directed) lambda
02

Mechanism of action

Inhibition of DNA polymerase catalytic activity and dRP lyase activity to prevent DNA repair and sensitize cells to genotoxic agents [4, 10, 11].

03

Biological functions

DNA repair [1, 3]Non-homologous end joining (NHEJ) [3, 5]Base excision repair (BER) [3, 6]Translesion synthesis (TLS) [5, 17]V(D)J recombination [3, 8]Cell cycle progression [9, 15]
04

Disease associations

Cancer [4, 6, 9]Genetic instability [6, 9, 17]
05

Safety considerations

Increased genetic instability [6, 9]Potential impairment of V(D)J recombination [3, 8]Redundancy with DNA polymerase beta [6, 15]
06

Interacting drugs

Rhodanine derivatives [4, 11]

3 more in the full profile.

07

Biomarkers

POLL expression levels [9]rs3730477 germline variant [9]T204 phosphorylation status [9]

Beyond the preview

Go deeper on DNA polymerase lambda (Pol λ) (Pol λ).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA polymerase lambda (Pol λ) (Pol λ).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call